methyl-prednisolonate and Multiple-Sclerosis

methyl-prednisolonate has been researched along with Multiple-Sclerosis* in 1 studies

Other Studies

1 other study(ies) available for methyl-prednisolonate and Multiple-Sclerosis

ArticleYear
Modulation of Th17 Proliferation and IL-17A Gene Expression by Acetylated Form of Apigenin in Patients with Multiple Sclerosis.
    Immunological investigations, 2021, Volume: 50, Issue:2-3

    The presence of Th17 cells in CNS lesion of MS patients due to their inflammatory cytokines secretion is in line with the deterioration of the disease. Currently, the use of natural compounds with anti-inflammatory properties such as flavonoids have been considered to reduce inflammation in these patients, but the remaining issue is how deliver these compounds to the site of inflammation. Acetylation is a way to better uptake compound by cells and cross through cellular layers with tight junctions. This study aimed to investigate the

    Topics: Acetylation; Adult; Anti-Inflammatory Agents; Apigenin; Cell Proliferation; Cells, Cultured; Female; Gene Expression Regulation; Humans; Immunomodulation; Interleukin-17; Male; Middle Aged; Multiple Sclerosis; Prednisolone; Th17 Cells; Young Adult

2021